Preimplantation genetic diagnosis (PGD) is a genetic screening procedure used in conjunction with assisted reproductive technology (ART), such as IVF, to help couples increase their chances of having a healthy pregnancy. This advanced technique involves testing embryos for chromosomal abnormalities that can lead to genetic disorders.
PGD was first developed in 1989 by Alan Handyside as a means to detect cystic fibrosis in embryos created through IVF. It was also used for sex selection, as male embryos are at a higher risk of certain sex-linked diseases. Over time, PGD has evolved into a sophisticated genetic testing method that can identify single-gene disorders, chromosomal abnormalities, and sex-related conditions.
Increased chances of a healthy pregnancy: By selecting embryos without genetic disorders, PGD can significantly improve the chances of a successful pregnancy and the birth of a healthy child.
Reduced risk of genetic disorders: PGD can help couples avoid passing on serious genetic conditions to their children.
Peace of mind: Knowing that their child is free from genetic defects can provide couples with a sense of peace and reassurance.
Mon to Sat: 11:00 – 05:00
Or you can ask the coordinator